1. United Kingdom National Health Service. Atopic eczema: Symptoms. Available at: https://www.nhs.uk/conditions/atopic-eczema/symptoms/. Accessed November 2022.
  2. American Academy of Allergy Asthma and Immunology. Eczema (atopic dermatitis) overview. Available at:
    https://www.aaaai.org/Tools-for-the-Public/Conditions-Library/Allergies/Eczema-(Atopic-Dermatitis)-Overview. Accessed November 2022.
  3. Data on file. Pfizer.
  4. National Eczema Association. Atopic dermatitis. Available at: https://nationaleczema.org/eczema/types-of-eczema/atopic-dermatitis/. Accessed November 2022.
  5. United Kingdom National Health Service. Atopic eczema: Causes. Available at: https://www.nhs.uk/conditions/atopic-eczema/causes/. Accessed November 2022.
  6. Eichenfield LF, Call RS, Forsha DW, et al. J Am Acad Dermatol. 2017;77(4):641-649.
  7. STAQUIS™ (crisaborole) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version June 2020.
  8. Kaufman MB. P T. 2017;42(2):90-91.
  9. Bissonnette R, Pavel AB, Diaz A, et al. J Allergy Clin Immunol. 2019;144(5):1274-1289.
  10. Paller AS, Tom WL, Lebwohl MG, et al. J Am Acad Dermatol. 2016; 75(3):494-503.
  11. Callender VS, Alexis AF, Stein Gold LF, et al. Am J Clin Dermatol. 2019;20(5):711-723.
  12. Yosipovitch G, Simpson EL, Tan H, et al. Itch. 2018;3(2):e12.
  13. Eucrisa® (crisaborole) US Prescribing Information. Pfizer Inc: Version March 2020.
  14. Eucrisa® (crisaborole) US Patient Information. Pfizer Inc: Version March 2020.